ArticleFrontiers in immunology2021

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens.

Gitte Holmen Olofsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.